Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Institutional Investor > Aisling Capital Management Lp > Profile

Instuitional Investor - Aisling Capital Management Lp

Fund Profile
Filing Period:
Fund Name: Aisling Capital Management Lp
Portfolio Value $359,671,696
Top 13F Holdings
Filing Period:
No. Security Ticker Shares Value % Port
1.
Bridgebio Pharma Inc.
 BBIO 6,068,125 $262,021,638 72.85%
2.
Verona Pharma Plc
 VRNA 615,352 $58,199,992 16.18%
3.
Syndax Pharmaceuticals Inc
 SNDX 1,316,806 $12,325,304 3.43%
4.
Monte Rosa Therapeutics Inc.
 GLUE 1,472,331 $6,640,213 1.85%
5.
Bicara Therapeutics Inc. (Bcax)
 568,919 $5,285,258 1.47%
Insider Monkey Quarterly Strategy
+373.4% Insider Monkey Quarterly Strategy
+154.9% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through February 19th, 2025)